Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man

Lars Berglund, Richard A. Galbraith, Lennart Emtestam, George S. Drummond, Bo Angelin, Attallah Kappas

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sn protoporphyrin (SnPP) and Sn mesoporphyrin (SnMP), potent inhibitors of heme oxygenase (HO), significantly suppress bilirubin production, lower serum and biliary bilirubin levels and increase biliary heme output in animals and man. In this study, 20 healthy volunteers, 7 patients with primary biliary cirrhosis and 4 patients with idiopathic hemochromatosis were treated with SnPP and 4 healthy volunteers with SnMP. In all cases, serum ferritin levels increased substantially but transiently after administration of these HO inhibitors. Values returned to baseline within a few days. Infusion of hematin in 4 healthy volunteers did not significantly affect ferritin levels. No increases occurred in 7 other acute-phase reactants. The observation that these HO inhibitors transiently increase serum ferritin levels implies a link between ferritin, iron metabolism and HO activity which may be usefully explored in disorders of iron metabolism.

Original languageEnglish (US)
Pages (from-to)51-56
Number of pages6
JournalPharmacology
Volume59
Issue number1
DOIs
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

Heme Oxygenase (Decyclizing)
Acute-Phase Proteins
Ferritins
Healthy Volunteers
Serum
Bilirubin
Iron Metabolism Disorders
Hemin
Hemochromatosis
Biliary Liver Cirrhosis
Heme
Iron
tin mesoporphyrin
tin protoporphyrin IX

Keywords

  • Bilirubin
  • Ferritin
  • Heme
  • Heme oxygenase inhibitors
  • Iron metabolism

ASJC Scopus subject areas

  • Pharmacology

Cite this

Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man. / Berglund, Lars; Galbraith, Richard A.; Emtestam, Lennart; Drummond, George S.; Angelin, Bo; Kappas, Attallah.

In: Pharmacology, Vol. 59, No. 1, 07.1999, p. 51-56.

Research output: Contribution to journalArticle

Berglund, Lars ; Galbraith, Richard A. ; Emtestam, Lennart ; Drummond, George S. ; Angelin, Bo ; Kappas, Attallah. / Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man. In: Pharmacology. 1999 ; Vol. 59, No. 1. pp. 51-56.
@article{1473a0b1722c4b1aa3c73bce47a2f029,
title = "Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man",
abstract = "Sn protoporphyrin (SnPP) and Sn mesoporphyrin (SnMP), potent inhibitors of heme oxygenase (HO), significantly suppress bilirubin production, lower serum and biliary bilirubin levels and increase biliary heme output in animals and man. In this study, 20 healthy volunteers, 7 patients with primary biliary cirrhosis and 4 patients with idiopathic hemochromatosis were treated with SnPP and 4 healthy volunteers with SnMP. In all cases, serum ferritin levels increased substantially but transiently after administration of these HO inhibitors. Values returned to baseline within a few days. Infusion of hematin in 4 healthy volunteers did not significantly affect ferritin levels. No increases occurred in 7 other acute-phase reactants. The observation that these HO inhibitors transiently increase serum ferritin levels implies a link between ferritin, iron metabolism and HO activity which may be usefully explored in disorders of iron metabolism.",
keywords = "Bilirubin, Ferritin, Heme, Heme oxygenase inhibitors, Iron metabolism",
author = "Lars Berglund and Galbraith, {Richard A.} and Lennart Emtestam and Drummond, {George S.} and Bo Angelin and Attallah Kappas",
year = "1999",
month = "7",
doi = "10.1159/000028305",
language = "English (US)",
volume = "59",
pages = "51--56",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man

AU - Berglund, Lars

AU - Galbraith, Richard A.

AU - Emtestam, Lennart

AU - Drummond, George S.

AU - Angelin, Bo

AU - Kappas, Attallah

PY - 1999/7

Y1 - 1999/7

N2 - Sn protoporphyrin (SnPP) and Sn mesoporphyrin (SnMP), potent inhibitors of heme oxygenase (HO), significantly suppress bilirubin production, lower serum and biliary bilirubin levels and increase biliary heme output in animals and man. In this study, 20 healthy volunteers, 7 patients with primary biliary cirrhosis and 4 patients with idiopathic hemochromatosis were treated with SnPP and 4 healthy volunteers with SnMP. In all cases, serum ferritin levels increased substantially but transiently after administration of these HO inhibitors. Values returned to baseline within a few days. Infusion of hematin in 4 healthy volunteers did not significantly affect ferritin levels. No increases occurred in 7 other acute-phase reactants. The observation that these HO inhibitors transiently increase serum ferritin levels implies a link between ferritin, iron metabolism and HO activity which may be usefully explored in disorders of iron metabolism.

AB - Sn protoporphyrin (SnPP) and Sn mesoporphyrin (SnMP), potent inhibitors of heme oxygenase (HO), significantly suppress bilirubin production, lower serum and biliary bilirubin levels and increase biliary heme output in animals and man. In this study, 20 healthy volunteers, 7 patients with primary biliary cirrhosis and 4 patients with idiopathic hemochromatosis were treated with SnPP and 4 healthy volunteers with SnMP. In all cases, serum ferritin levels increased substantially but transiently after administration of these HO inhibitors. Values returned to baseline within a few days. Infusion of hematin in 4 healthy volunteers did not significantly affect ferritin levels. No increases occurred in 7 other acute-phase reactants. The observation that these HO inhibitors transiently increase serum ferritin levels implies a link between ferritin, iron metabolism and HO activity which may be usefully explored in disorders of iron metabolism.

KW - Bilirubin

KW - Ferritin

KW - Heme

KW - Heme oxygenase inhibitors

KW - Iron metabolism

UR - http://www.scopus.com/inward/record.url?scp=0033044953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033044953&partnerID=8YFLogxK

U2 - 10.1159/000028305

DO - 10.1159/000028305

M3 - Article

VL - 59

SP - 51

EP - 56

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 1

ER -